Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899275 · ClinicalTrials.gov registry record
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 957
- Enrollment target
NCT00899275: Completed study, sponsored by Children's Oncology Group.
NCT00899275 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 957 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899275 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 957 participants
- Enrollment target
Study Summary
The purpose of this study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma. Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
Interventions
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 957 participants |
| Start Date | 2008-02-04 |
| Est. Completion | 2023-09-30 |
What the finished NCT00899275 record still lists
NCT00899275 is an observational study that tracks outcomes without assigning an intervention. The registered 957 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cytology Specimen Collection Procedure is the first listed.
NCT00899275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899275 about?
NCT00899275 is a clinical study titled "Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma". The purpose of this study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma. Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
What is the current status of trial NCT00899275?
This trial is currently completed. The enrollment target is 957 participants. The study started on 2008-02-04. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT00899275?
The interventions under investigation include: Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT00899275?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06259669 · 958 participants
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- NCT06225596 · 956 participants · Phase 2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI